Swiss National Bank’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-86,300
| Closed | -$631K | – | 2540 |
|
|
2023
Q3 | $631K | Buy |
86,300
+1,900
| +2% | +$15.8K | ﹤0.01% | 2448 |
|
|
2023
Q2 | $880K | Hold |
84,400
| – | – | ﹤0.01% | 2358 |
|
|
2023
Q1 | $873K | Sell |
84,400
-9,700
| -10% | -$124K | ﹤0.01% | 2327 |
|
|
2022
Q4 | $1.3M | Buy |
94,100
+2,800
| +3% | +$39K | ﹤0.01% | 2178 |
|
|
2022
Q3 | $1.87M | Hold |
91,300
| – | – | ﹤0.01% | 1920 |
|
|
2022
Q2 | $1.77M | Hold |
91,300
| – | – | ﹤0.01% | 2009 |
|
|
2022
Q1 | $1.97M | Buy |
91,300
+6,600
| +8% | +$150K | ﹤0.01% | 2049 |
|
|
2021
Q4 | $2.34M | Buy |
84,700
+1,000
| +1% | +$27.6K | ﹤0.01% | 1952 |
|
|
2021
Q3 | $2.17M | Hold |
83,700
| – | – | ﹤0.01% | 1998 |
|
|
2021
Q2 | $2.27M | Sell |
83,700
-2,200
| -3% | -$53.7K | ﹤0.01% | 2026 |
|
|
2021
Q1 | $2.01M | Hold |
85,900
| – | – | ﹤0.01% | 1998 |
|
|
2020
Q4 | $1.32M | Hold |
85,900
| – | – | ﹤0.01% | 2159 |
|
|
2020
Q3 | $1.04M | Hold |
85,900
| – | – | ﹤0.01% | 2071 |
|
|
2020
Q2 | $874K | Buy |
85,900
+12,900
| +18% | +$133K | ﹤0.01% | 2184 |
|
|
2020
Q1 | $761K | Buy |
73,000
+1,700
| +2% | +$21.3K | ﹤0.01% | 1979 |
|
|
2019
Q4 | $1.14M | Buy |
71,300
+2,200
| +3% | +$33.6K | ﹤0.01% | 2065 |
|
|
2019
Q3 | $1.27M | Hold |
69,100
| – | – | ﹤0.01% | 1926 |
|
|
2019
Q2 | $1.36M | Buy |
69,100
+1,400
| +2% | +$28.5K | ﹤0.01% | 1937 |
|
|
2019
Q1 | $1.55M | Buy |
67,700
+1,400
| +2% | +$30.4K | ﹤0.01% | 1820 |
|
|
2018
Q4 | $1.33M | Hold |
66,300
| – | – | ﹤0.01% | 1823 |
|
|
2018
Q3 | $1.44M | Hold |
66,300
| – | – | ﹤0.01% | 1926 |
|
|
2018
Q2 | $1.48M | Buy |
66,300
+5,300
| +9% | +$108K | ﹤0.01% | 1919 |
|
|
2018
Q1 | $1.05M | Hold |
61,000
| – | – | ﹤0.01% | 2045 |
|
|
2017
Q4 | $1.01M | Hold |
61,000
| – | – | ﹤0.01% | 2091 |
|
|
2017
Q3 | $1.04M | Hold |
61,000
| – | – | ﹤0.01% | 2039 |
|
|
2017
Q2 | $989K | Buy |
61,000
+5,200
| +9% | +$82.2K | ﹤0.01% | 2062 |
|
|
2017
Q1 | $968K | Hold |
55,800
| – | – | ﹤0.01% | 2058 |
|
|
2016
Q4 | $941K | Buy |
55,800
+6,500
| +13% | +$108K | ﹤0.01% | 2074 |
|
|
2016
Q3 | $865K | Buy |
49,300
+400
| +0.8% | +$6.49K | ﹤0.01% | 2065 |
|
|
2016
Q2 | $703K | Hold |
48,900
| – | – | ﹤0.01% | 2168 |
|
|
2016
Q1 | $582K | Buy |
48,900
+8,300
| +20% | +$91.7K | ﹤0.01% | 2222 |
|
|
2015
Q4 | $493K | Hold |
40,600
| – | – | ﹤0.01% | 2274 |
|
|
2015
Q3 | $536K | Buy |
40,600
+4,600
| +13% | +$69.5K | ﹤0.01% | 2151 |
|
|
2015
Q2 | $590K | Buy |
36,000
+1,200
| +3% | +$19.9K | ﹤0.01% | 2144 |
|
|
2015
Q1 | $619K | Buy |
34,800
+7,300
| +27% | +$136K | ﹤0.01% | 2054 |
|
|
2014
Q4 | $523K | Hold |
27,500
| – | – | ﹤0.01% | 2148 |
|
|
2014
Q3 | $377K | Hold |
27,500
| – | – | ﹤0.01% | 2253 |
|
|
2014
Q2 | $449K | Hold |
27,500
| – | – | ﹤0.01% | 2220 |
|
|
2014
Q1 | $433K | Buy |
27,500
+6,800
| +33% | +$111K | ﹤0.01% | 2194 |
|
|
2013
Q4 | $356K | Hold |
20,700
| – | – | ﹤0.01% | 2192 |
|
|
2013
Q3 | $273K | Sell |
20,700
-1,600
| -7% | -$18.9K | ﹤0.01% | 2260 |
|
|
2013
Q2 | $252K | Buy |
+22,300
| New | +$237K | ﹤0.01% | 2291 |
|
Other funds holding ANGO
SFM
Swiss National Bank's ANGO Position: Q4 2023 in Review
Swiss National Bank sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 86,300 shares — an estimated $631K sold.
Swiss National Bank first reported a position in ANGO in Q2 2013 and held it in 42 quarters. The position peaked at $2.34M in Q4 2021. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.
- Swiss National Bank reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
- Swiss National Bank sold 86,300 AngioDynamics shares in Q4 2023, an estimated $631K.
- Swiss National Bank first reported a position in AngioDynamics in Q2 2013 and held it in 42 quarters.
- Swiss National Bank's AngioDynamics position peaked at $2.34M in Q4 2021.
- 150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.
Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.